drugset / Trial / NCT03150173

Onsite Buprenorphine Treatment at Syringe Exchange Programs

NCT03150173

RandomizedParallel-groupOpen-labelTreatment

Summary

This trial will recruit syringe exchange participants with opioid use disorder in New York City and test whether starting buprenorphine treatment at the syringe exchange program is more effective than referral to a community health center for buprenorphine treatment.

Timeline

Start
2019-01-02
Primary completion
2023-10-11
Completion
2024-03-31

Drugs

EvaluationDrugModalityDoseRoute
Background Buprenorphine Other / unclassified

Indications